Cite
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis
MLA
Federica, Macaluso, et al. “Safety and Efficacy of Secukinumab Treatment in a Patient with Ankylosing Spondylitis and Concomitant Multiple Sclerosis.” Clinical and Experimental Rheumatology, vol. 37, no. 6, Mar. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........527cee1dac62886096e8ed8b20962454&authtype=sso&custid=ns315887.
APA
Federica, M., Giuliana, G., Daniele, M., Chiara, R., Rodolfo, B., & Francesco, C. (2019). Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis. Clinical and Experimental Rheumatology, 37(6).
Chicago
Federica, Macaluso, Guggino Giuliana, Mauro Daniele, Rizzo Chiara, Bignone Rodolfo, and Ciccia Francesco. 2019. “Safety and Efficacy of Secukinumab Treatment in a Patient with Ankylosing Spondylitis and Concomitant Multiple Sclerosis.” Clinical and Experimental Rheumatology 37 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........527cee1dac62886096e8ed8b20962454&authtype=sso&custid=ns315887.